2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量：1511
3Wang Y, Monteiro C, Popkin BM. Trends of obesity and underweight in older children and adolescents in the United States, Brazil, China, and Russia. Am J Clin Nutr, 2002, 75: 971-977.
4Charlton M, Kasparova P, Weston S, et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl, 2001, 7: 608-614.
5Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr, 2000, 136: 727-733.
6Park HS, Han JH, Choi KM, et al. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr, 2005, 82: 1046-1051.
7Tominaga K, Kurata JH, Chen YK, et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci, 1995, 40: 2002-2009.
8Quiros-Tejeira RE, Rivera CA, Ziba TT, et al. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI＞or=95th percentile. J Pediatr Gastroenterol Nutr, 2007, 44: 228-236.
9de Silva KS, Wickramasinghe VP, Gooneratne IN. Metabolic consequences of childhood obesity--a preliminary report. Ceylon Med J, 2006, 51: 105-109.
10Chart DE Li AM, Chu WC, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord, 2004, 28: 1257-1263.
1Despre's JP, Golay A, Sjostrom L. Effects on metabolic risk factors in overweight patients with dyslipidemia[ J]. N Engl J IVied, 2005,353:2121 - 2134.
2Hama A, Sagen J. Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuro- pathic spinal cord injury pain [ J ]. J Rehabil Res Dev, 2009,46 (1) :135 -143.
3Hong S, Fan J, Kemmerer ES, et al. Reciprocal changes in vanilloid(TRPVl ) and endocannabinoid(CB1 ) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat [ J ]. Gut,2009,58 (2) :202 -210.
4Maldonado R. The endogenous opioid system and drug addiction[J]. Ann Pharm Fr,2010,68(1) :3 -11.
5Rossi S, De Chiara C, Musella M, et al. Effects of caffeine on striFocus on cannabinoid CB1 receptors [ J] Mol. Nutr. Food Res,2010,54(4) :525 -531.
6Zvonok N, Xu W, Willians J, et al. Mass spectrometry-basedGPCR proteomics: comprehensive characterization of the human cannabinoid 1 receptor [ J ]. J Proteome Res, 2010,9 ( 4 ) 1746 - 1753.
7Di Marzo V, Matias I. Endocannabinoid control of food intake and energy balance [ J ]. Nat Neurosci ,2005,8:585 - 589.
8Di Matzo V. Targeting the endoeannabinoid system:to enhance or reduce[ J]. Nat Rev Drug Discov ,2008 ,7 :438 - 455.
10Mouslech Z, Valla V. Endocannabinoid system:an overview of its potential in current medical practice [ J ]. Neuro Endocrinol Lett, 2009,30(2) :153 - 179.
